70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Generation Bio’s ctLNP platform enables delivery of RNA and ...

The approval of messenger RNA (mRNA) based COVID-19 vaccines marked a pivotal scientific milestone, establishing mRNA as an innovative drug modality with immense therapeutic potential. However, due to ...

Oral presentation describes machine learning-guided multiparameter optimization of lipid nanoparticles (LNPs) to achieve selective delivery to adipose tissue Two poster presentations highlight Mirai’s ...

LNP–mRNA drug products are produced by mixing the nucleic acid drug substance with various lipid components, such as phospholipids, cholesterol, PEG–lipids and ionizable lipids, resulting in a ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station. Thanks to international ...

Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study. First biodistribution study of the Company’s complete ...

Authorization expands academic and industry researcher access for LNP delivery optimization, mRNA vaccine development and gene therapy research A new agreement between Promega Corporation and the RNA ...

Under the two-year project timeline, researchers will spend the first year optimizing vaccine candidates and evaluating their ...